Clomiphene Citrate USP Active Pharmaceutical Ingredient (CAS : 50-41-9), 1 KG recall — Shimoga Chemicals (Class II)
Shimoga Chemicals is recorded by the U.S. Food and Drug Administration (FDA) as recalling Clomiphene Citrate USP Active Pharmaceutical Ingredient (CAS : 50-41-9), 1 KG — a Class II recall, initiated 2026-05-19 and posted to the FDA enforcement report on 2026-07-15, under recall number D-0691-2026. Status Ongoing, with no termination date on the record. The reason the FDA record carries is, verbatim: “cGMP deviations”. From the product description, the strengths given are 1 KG, 500 g and 100 g and it is marked Rx only. 3 National Drug Code numbers are printed in the record: 84849-000-01, 84849-000-02 and 84849-000-03. Distribution is recorded as “CA & FL only” — Limited / regional distribution, with the recalling firm on record in N/A, India. It is the only recall number the FDA has filed under event ID 99232. Values are reproduced from the linked openFDA report; regulatory information, not medical advice.
Regulatory snapshot
| Recall number | D-0691-2026 |
|---|---|
| FDA event ID | 99232 |
| Classification | Class II (intermediate regulatory tier) |
| Status | Ongoing |
| Recalling firm | Shimoga Chemicals |
| Recall initiated | 2026-05-19 |
| Reported by FDA | 2026-07-15 |
| Report lag | 57 days from initiation to report |
| Distribution | CA & FL only — Limited / regional distribution |
| Firm location on record | N/A, India |
| Product description (source) | Clomiphene Citrate USP Active Pharmaceutical Ingredient (CAS : 50-41-9), Net Weight a)1 KG (NDC 84849-000-01), b) 500 g (NDC 84849-000-02), (c) 100 g (NDC 84849-000-03), Rx Only, Shimoga Chemicals Address -W-57A, MIDC Kupwad Samgli, Maharashtra, 416436, India. |
Reason reported by FDA
cGMP deviations
2 words from the enforcement report field reason_for_recall, reproduced without edit — the firm's own wording, not an assessment.
Product identifiers in this record
7 identifying values matched by exact pattern in the 37-word product description above; each is a literal substring of it.
| Product named | Clomiphene Citrate USP Active Pharmaceutical Ingredient (CAS : 50-41-9) |
|---|---|
| Strength | 1 KG · 500 g · 100 g |
| NDC | 84849-000-01 · 84849-000-02 · 84849-000-03 |
| Marketing category | Rx only |
Other Class II recalls with India on record
27 indexed records carry India as the recalling firm's country, against a dataset that is predominantly United States. These are the ones that also share this recall's FDA tier.
| Recall record | Recall number | Recalling firm | Strength / form | Reported |
|---|---|---|---|---|
| Methohexital Sodium for Injection, 500 mg | D-0662-2026 | Onesource Specialty Pharma Ltd | 500 mg · for Injection | 2026-07-15 |
| Pemetrexed for Injection 100mg/Vial | D-0671-2026 | Reliance Life Sciences Private Ltd | 100mg/Vial · for Injection | 2026-07-15 |
| Pemetrexed for Injection 500mg/Vial | D-0672-2026 | Reliance Life Sciences Private Ltd | 500mg/Vial · for Injection | 2026-07-15 |
| Bortezomib for Injection 3.5mg/Vial | D-0673-2026 | Reliance Life Sciences Private Ltd | 3.5mg/Vial · for Injection | 2026-07-15 |
| Azacitidine for Injection 100mg/Vial | D-0674-2026 | Reliance Life Sciences Private Ltd | 100mg/Vial · for Injection | 2026-07-15 |
| Lacosamide Tablets, 100mg | D-0626-2026 | Annora Pharma Private Ltd | 100mg · Tablets | 2026-07-01 |
Reported in the same month (2026-07)
111 enforcement reports carry a report date in 2026-07; these 8 are the Class II ones nearest this record.
| Recall record | Recall number | Recalling firm | FDA tier | Reported |
|---|---|---|---|---|
| Medline Remedy Specialized Silicone Cream (Hydraguard-D ), 59 mL | D-0663-2026 | Biomed Laboratories, Llc. | Class II | 2026-07-15 |
| Methohexital Sodium, 100 mg/10 mL | D-0664-2026 | Quva Pharma, Inc. | Class II | 2026-07-15 |
| Gasco Isopropyl Alcohol 70% | D-0665-2026 | Gasco Industrial Corp. | Class II | 2026-07-15 |
| Gasco Isopropyl Alcohol 70% | D-0666-2026 | Gasco Industrial Corp. | Class II | 2026-07-15 |
| Gasco Isopropyl Alcohol 70% | D-0667-2026 | Gasco Industrial Corp. | Class II | 2026-07-15 |
| Drogueria San Juan Puerto Rico Isopropyl Alcohol 70% | D-0668-2026 | Gasco Industrial Corp. | Class II | 2026-07-15 |
| Drogueria San Juan Puerto Rico Isopropyl Alcohol 70% | D-0669-2026 | Gasco Industrial Corp. | Class II | 2026-07-15 |
| Drogueria San Juan Puerto Rico Isopropyl Alcohol 70% | D-0670-2026 | Gasco Industrial Corp. | Class II | 2026-07-15 |
Nearest Class II recalls by date
213 of 250 indexed records share the Class II tier; the 2 nearest to 2026-07-15 by report date are listed here.
| Recall record | Recall number | Recalling firm | Strength / form | Reported |
|---|---|---|---|---|
| BD ChloraPrep Hi-Lite Orange, 2% | D-0643-2026 | Carefusion 213, LLC | 2% · Solution | 2026-07-08 |
| BD PurPrep, 8.3% | D-0644-2026 | Carefusion 213, LLC | 8.3% · Solution | 2026-07-08 |
Reading this record
Class II is the FDA's own severity tier for the recall action — 213 of the 250 indexed records carry it — and it describes the agency's assessment of the action, not a risk statement about any individual. Match a package against 84849-000-01, 84849-000-02 and 84849-000-03 at the FDA source to confirm it is covered.
Namespace context: the Class II index (213 records) and the recall hub (250 records, 118 FDA events); Shimoga Chemicals (1 indexed records) aggregates this firm across datasets.
Coverage and limits of this record
This page reflects the openFDA enforcement report for D-0691-2026 as ingested on 2026-08-22, which can lag the live FDA record and omits detail held only in primary documents. It offers no clinical assessment, no advice about whether to use any product, and no substitute. For any health question consult a qualified healthcare professional.
Source & provenance
- Official source
- https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0691-2026%22
- Source dataset
- openFDA Drug Enforcement API
- Publication date
- 2026-07-15
- Ingested
- 2026-08-22
- Record hash
221d5a4c1e334e37
Verify every value against the official FDA source above. This site links to the regulator's record rather than replacing it.